In vitro interaction of C1-inhibitor with thrombin

Blood Coagulation and Fibrinolysis

Volumn 12, Issue 4, 2001, Pages 253-260

  Cugno, Massimo ^a   Bos, I ^b   Lubbers, Y ^b   Hack, C Erik ^b   Agostoni, A ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

C1 inhibitor; Complement; Contact system; Heparin; Thrombin

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; HEPARIN; THROMBIN;

ANGIONEUROTIC EDEMA; ARTICLE; BLOOD CLOTTING; COMPLEMENT SYSTEM; CONTROLLED STUDY; ENDOTHELIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IN VITRO STUDY; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REACTION TIME; THROMBIN TIME;

COMPLEMENT C1 INACTIVATOR PROTEINS; COMPLEMENT C1 INHIBITOR PROTEIN; HUMANS; IMMUNOASSAY; KINETICS; PROTEIN BINDING; THROMBIN;

EID: 0034968591     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200106000-00005     Document Type: Article

References (23)

1. C1 inhibitor and hereditary angioneurotic edema
2. Studies on human plasma C1-inactivator-enzyme interaction I. Mechanisms of interaction with C1s, plasmin and trypsin
3. Interaction of C1 inhibitor with the C1r and C1s subcomponents in human C1
4. Inhibition of Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator
5. Interaction of plasma kallikrein with the C1 inhibitor
6. Inhibition of C1-INH of Hageman factor fragment activation of coagulation, fibrinolysis, and kinin generation
7. Biochemistry and pathophysiology of human C1 inhibitor: Current issues
8. Proteolytic cleavage and inactivation of α2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastase
9. Activation of the coagulation cascade in C1 inhibitor deficiencies
10. Studies on human plasma C1-inactivator-enzyme interactions I. Mechanisms of interaction with C1s, plasmin and trypsin
11. Functional and structural similarities between protease nexin I and C1 inhibitor
12. Overview of hemostasis
13. Thrombin induced increase in albumin permeability across the endothelium
14. Vascular endothelial cell activation and permeability responses to thrombin
15. A new simplified procedure for C1 inhibitor purification. A novel use for jacalin-agarose
16. The role of factor VIII in the activation of human blood coagulation factor X by activated factor IX
17. Quantification of plasma factor XIIa-C1-inhibitor and kallikrein-C1-inhibitor complexes in sepsis
18. Proteolytic inactivation of plasma C1-inhibitor in sepsis
19. Inactivation of C1-inhibitor by proteases: Demonstration by a monoclonal antibody of a neodeterminant on inactivated, non-compexed C1-inhibitor
20. Interleukin-1 blockade attenuates mediator release and dysregulation of the hemostatic mechanism during human sepsis
21. Modulation of contact system proteases by glycosaminoglycans. Selective enhancement of the inhibition of factor XIa
22. Effect of C1 inhibitor on inflammatory and physiologic response patterns in primated suffering from lethal septic shock
23. α-2-macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient children